Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about the safety and efficacy of Dasatinib in
combination with Capecitabine for patients with advanced breast cancer, and who have received
treatment with a taxane and an anthracycline